41
diseases-(cvds); 2021 (diakses 5 Apr 2022).
2. World Bank. New World Bank country classifications by income level:
2021-2022. 2021. Diunduh dari:
https://blogs.worldbank.org/opendata/new-world-bank-country- classifications-income-level-2021-2022; 2021 (diakses 17 Mei 2022).
3. Kementrian Kesehatan RI. Riskesdas 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2013.
4. Morrow DA. Myocardial Infarction A Companion to Braunwald’s Heart Disease. Missouri: Elsevier; 2017.
5. Surendran A, Atefi N, Zhang H, et al. Defining Acute Coronary Syndrome through Metabolomics. Metabolites. 2021;11(685):1.
6. Singh A, Museedi AS, Grossman SA. Acute Coronary Syndrome.
Treasure Island (FL): StatPearls Publishing; 2021.
7. Kusumawati E, Firdaus AAA, Putra RHM. Hubungan antara Kadar Troponin dengan Kejadian Major Adverse Cardiovascular Events pada Pasien Sindrom Koroner Akut di RSI Jemuran Surabaya. Medical and Health Science Journal. 2018;2(1):48.
8. Than MP, et al. Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk:
An Observational Study. Clinical Chemistry. 2018;64(7):1050.
9. Mohammadzadeh S, Matani N, Soleimani N, Bazrafshan drissi H.
Comparison of Point-of-Care and Highly Sensitive Laboratory Troponin Testing in Patients Suspicious of Acute Myocardial Infarction and Its Efficacy in Clinical Outcome. Hindawi Cardiology Research and Practice.
2022;22(1):1-7.
10. Lima BB, Hammadah M, Kim JH, et al. Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease. Am J Cardiol. 2020 Dec 1;136:1-8.
11. Kumar P, Clark M. Kumar & Clark’s Clinical Medicine. 7th Ed.
Philadelphia: Elsevier; 2009.
12. Tanto C, et al. Kapita Selekta Kedokteran. Edisi ke-4. Jakarta: Media Aesculapius; 2016.
13. Runge MS, Greganti MA. Netter’s Internal Medicine. Philadelphia:
Elsevier; 2008.
14. Loscalzo J. Harrison’s Cardiovascular Medicine. New York: The McGraw Hill; 2010.
15. Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. Buku Ajar Ilmu Penyakit Dalam. Jakarta: Interna Publishing; 2017.
16. Poudel I, Tejpal C, Rashid H, Jahan N. Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review. Cureus 2019;11(7):e5280.
17. Ralapanawa U, Kumarasiri PVR, et al. Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC Cardiovasc Disord. 2019;19(1):229.
18. PERKI. Pedoman Tatalaksana Sindrom Koroner Akut. Edisi ke-4. Jakarta:
PP PERKI; 2018.
19. Crea F, Libby P. Acute Coronary Syndromes The Way Forward From Mechanisms to Precision Treatment. Circulation. 2017;136:1155–1166.
20. Gach O, El Husseini Z, Lancellotti P. Syndrome coronarien aigu. Rev Med Liege 2018; 73(5): 243-250.
21. PERKI. Panduan Praktik Klinis & Clinical Pathway Penyakit Jantung dan Pembuluh Darah. Jakarta: PP PERKI; 2018.
22. Bickley LS, Szilagyi PG. Buku Ajar Pemeriksaan Fisik dan Riwayat Kesehatan. Edisi 11. Jakarta: EGC; 2015.
23. Barstow C, Rice M, McDivitt JD. Acute Coronary Syndrome: Diagnostic Evaluation. Am Fam Physician. 2017;95(3):170-177. PMID: 28145667.
24. Jacob R, Khan M. Cardiac Biomarkers: What Is and What Can Be. Indian J Cardiovasc Dis Women WINCARS. 2018;3(4):240-244.
25. Gupta V, Paranzino M, Alnabelsi T, et al. 5th generation vs 4th generation troponin T in predicting major adverse cardiovascular events and all-cause mortality in patients hospitalized for non-cardiac indications: A cohort study. PLOS ONE. 2021;16(2):3.
26. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovascular Research.
2017;113:1712.
27. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care. Clinical Chemistry. 2017;63(1):73–81.
28. Thygesen K, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. European Heart Journal. 2012;33:2252–2257.
29. Biomerieux Diagnostics. VIDAS High sensitive Troponin I. 2022.
Diunduh dari: https://www.biomerieux-diagnostics.com/vidasr-high- sensitive-troponin-i; 2022 (diakses 28 Des 2022).
30. Huether SE, McCance KL. Understanding Pathophysiology. 6th Ed.
Philadelphia: Elsevier; 2016.
31. Martalena D, Nasution SA, Purnamasari D, Harimurti K. Pengaruh Hiperglikemia Admisi terhadap Major Adverse Cardiovascular Events Selama Perawatan pada Pasien Sindrom Koroner Akut di ICCU RSCM Jakarta. eJKI. 2013;1(2):107.
32. Huang ZS, Zheng ZD, Zhang JW, et al. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center. European Review for Medical Pharmacological Sciences.
2020;24:3983.
33. Bosco E, Hsueh L, McConeghy KW, et al. Major adverse cardiovascular event defnitions used in observational analysis of administrative databases:
a systematic review. BMC Med Res Methodol. 2021;21:241.
34. Muhadi, Prihartono NA. Cedera Hati Hipoksik Prediktor Komplikasi Akut Utama Pasien Infark Miokard di Unit Rawat Intensif Koroner Rumah Sakit Cipto Mangunkusumo. Jurnal Penyakit Dalam Indonesia.
2018;5(3):117.
35. Zipes DP, Libby P, Bonow RO, Mann DL, Braunwald E. Braunwald’s Heart Disease. 11th Ed. Philadephia: Elsevier; 2018.
36. Yuniadi Y. Mengatasi Aritmia Mencegah Kematian Mendadak. eJKI.
2017;5(3):139.
37. Thio V. Gambaran Aritmia pada Pasien Sindrom Koroner Akut. Makassar:
FK Universitas Hasanuddin; 2020.
38. Hauser SL, Josephson SA. Harrison's Neurology in Clinical Medicine.
New York: The McGraw Hill; 2010.
39. Suyatno. Menghitung Besar Sampel Penelitian Kesehatan Masyarakat.
Semarang: FKM Undip; 2013.
40. Munirwan H, Ridwan M, Nurkhalis, et al. Profil Penderita Sindroma Koroner Akut di Rumah Sakit Umum Daerah dr. Zainoel Abidin Banda Aceh. Journal of Medical Science. 2021;1(1):11, 14.
41. Muhibbah, Wahid A, Agustina R, Illiandri O. Karakteristik Pasien Sindrom Koroner Akut pada Pasien Rawat Inap Ruang Tulip di RSUD Ulin Banjarmasin. Indonesian Journal for Health Sciences. 2019;3(1):8.
42. Demirel ME, Donmez I, Ucaroglu ER, Yuksel A. Acute Coronary Syndrome and Diagnostic Methods. Med Res Innov. 2019;3:1.
43. Sabebegen EMM, Yaswir R, Efrida. Gambaran Castelli’s Risk Index-1 pada Pasien Sindrom Koroner Akut di RSUP Dr. M. Djamil Padang.
Jurnal Kesehatan Andalas. 2021;10(2):104.
44. Nofer JR. Estrogen and Atherosclerosis: Insight from Animal Models and Cell Systems. Journal of Molecular Endocrinology. 2012;48:13-29.
45. Jamil M. Perbedaan Rerata Nilai Troponin pada Pasien Sindrom Koroner Akut dengan ST Elevasi dan Sindrom Koroner Akut tanpa ST Elevasi di ICCU RS Dr. Wahidin Sudirohusodo Makassar (Skripsi). Makassar: FK Universitas Hasanuddin; 2017.
46. Nisa RA. Gambaran Profil Penderita Sindrom Koroner Akut di RSUP H.
Adam Malik Medan (Skripsi). Medan: FK UMSU; 2017.
47. Wenas MF, Jim EL, Panda AL. Hubungan antara Rasio Kadar Kolesterol Total terhadap High Density Lipoprotein (HDL) dengan Kejadian Sindrom Koroner Akut di RSUP Prof. Dr. R. D Kandou Manado. Jurnal e-Clinic.
2017;5(2):184.
48. Fahrera MP, Susilo C, Adi GS. Hubungan Pengetahuan Kejadian Nyeri Dada dengan Respon Awal Pasien dalam Mencari Pertolongan Pertama pada Penyakit Jantung Koroner di Puskesmas Kalisat (Skripsi). Jember:
Fakultas Ilmu Kesehatan Universitas Muhammadiyah Jember; 2019.
49. Laksono S, Harsas NA. Arrhythmia in Acute Coronary Syndrome: Mini Review. Al-Iqra Medical Journal. 2022;5(1):41
50. Forth C, Gangwani MK, Alvey H. Ventricular Tachycardia. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
51. Rosa SA, Timoteo AT, Ferreira L, et al. Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcome. European Heart Journal: Acute Cardiovascular Care. 2018;7(3):
218–223
52. PERKI. Pedoman Tatalaksana Fibrilasi Atrium. Edisi ke-1. Jakarta: PP PERKI; 2014.
53. Vahdatpour C, Collins D, Goldberg S. Cardiogenic Shock. J Am Heart Assoc. 2019;8:e011991
54. Aninditha T, Wiratman W. Buku Ajar Neurologi. Jakarta: Departemen Neurologi FK UI RSCM; 2017.
55. Wong YK et al. High-sensitivity Troponin I and B-Type Natriuretic Peptide Biomarkers for Prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Cardiovasc Diabetol. 2019;18:171.
56. Daniel, Saputra F, Bagaswoto HP, Setianto BY. Association between the level of high-sensitivity troponin I (Hs-Trop I) and major adverse cardiovascular events in patients with acute myocardial infarction of segment elevation (STEMI) with primary percutaneous coronary intervention (PCI). J Med Sci. 2022;54(1):22.
